Access cutting-edge asthma treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access asthma specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related asthma treatment provided free
The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To evaluate the safety and tolerability of Fp/ABS eMDPI administered four times daily over four weeks * To investigate the pharmacokinetics of Fp/ABS eMDPI, ABS eMDPI and Fp eMDPI after administration of a single dose The
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Check if you qualify for this asthma clinical trial in Phoenix, AZ
If you're searching for asthma treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.